Altimmune, Inc. ALT

Set alert

Price alert · ALT

All alert types
2.07 USD +0.04 +2.23%

As of Nov 3, 1:50 PM ET

Bid
2.06 × 61
Ask
2.07 × 59
2.03 Day range 2.08
1.99 52-week range 6.44
YTD
-42.80%
1 year
-47.85%
Open
2.04
Prev close
2.02
Mkt cap
402.63M
Vol
949.27K
Avg vol
4.01M
EPS
-0.76
P/E
0.00
Div yield
0.00%
More statistics
Low
2.03
High
2.08
Forward P/E
-5.14
Beta
0.07
Short ratio
5.81
Inst. own
56.68%
Dividend
0.00
Ex-div date
Jan 19, 2017
50-d avg
7.91
200-d avg
7.41
1y target
22.86

30m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Signals (14)
NameTimeAgo
SMA: BullishNov 3, 9:55 AM3 hours ago
SMA: BullishNov 3, 9:55 AM3 hours ago
MACD: Buy SignalNov 3, 9:55 AM3 hours ago
MACD: Sell SignalNov 2, 1:55 PM23 hours ago
SMA: BearishNov 2, 1:25 PM1 day ago
SMA: BullishNov 2, 12:55 PM1 day ago
MACD: Buy SignalNov 2, 12:55 PM1 day ago
SMA: BearishNov 2, 12:25 PM1 day ago
MACD: Sell SignalNov 2, 12:25 PM1 day ago
MACD: Buy SignalNov 2, 11:55 AM1 day ago
MACD: Sell SignalNov 2, 11:25 AM1 day ago
MACD: Buy SignalNov 2, 10:25 AM1 day ago
RSI: OverboughtOct 29, 11:25 AM5 days ago
SMA: BullishOct 28, 3:55 PM5 days ago

Analyst view

Consensus: buy

Buy
Price target (mean) 22.86 +1006.9% upside
Target (low)
12.00
Target (mean)
22.86
Target (high)
28.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy4
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 9
  • 2 months ago 8
  • 3 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ALT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.24-0.39 – 3.02-0.3289+173.0%0-100.0%6
Next quarter-0.33667-0.35 – -0.32-0.34+1.0%1.00K-80.0%5
Current year-0.80333-1.40 – 1.96-1.43+43.7%3.57K-99.2%6
Next year-1.09-1.97 – 0.73-0.80333-36.1%28.57M+800300.2%6

Upgrades and downgrades

The latest rating changes

ALT analyst upgrades and downgrades
DateFirmActionFromTo
Nov 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 12, 2024UBSInitiated—Buy
Aug 12, 2024B. Riley SecuritiesReiteratedBuyBuy
Jun 25, 2024B. Riley SecuritiesReiteratedBuyBuy
Jun 21, 2024Piper SandlerMaintainedOverweightOverweight
May 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2024JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Apr 29, 2024GuggenheimDowngradeBuyNeutral
Apr 1, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 28, 2024B. Riley SecuritiesReiteratedBuyBuy
Feb 13, 2024B. Riley SecuritiesMaintainedBuyBuy
Dec 1, 2023HC Wainwright & Co.ReiteratedBuyBuy
Nov 9, 2023B. Riley SecuritiesMaintainedBuyBuy
Aug 14, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 11, 2023B. Riley SecuritiesMaintainedBuyBuy
Jul 12, 2023JMP SecuritiesReiteratedMarket OutperformMarket Outperform
May 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Mar 31, 2023JMP SecuritiesReiterated—Market Outperform
Mar 22, 2023JMP SecuritiesReiterated—Market Outperform
Mar 22, 2023Goldman SachsDowngradeBuyNeutral
Mar 9, 2023HC Wainwright & Co.Reiterated—Buy
Feb 6, 2023JMP SecuritiesReiterated—Market Outperform
Jan 20, 2023HC Wainwright & Co.Reiterated—Buy
Jan 18, 2023Evercore ISI GroupMaintained—Outperform
Dec 1, 2022Goldman SachsInitiated—Buy
Nov 11, 2022JMP SecuritiesMaintained—Market Outperform
Sep 16, 2022GuggenheimMaintained—Buy
Aug 31, 2022JefferiesMaintained—Buy
Aug 17, 2022HC Wainwright & Co.Maintained—Buy
Aug 12, 2022B. Riley SecuritiesMaintained—Buy